Paraneoplastic endocrine syndromes

Curr Ther Endocrinol Metab. 1994:5:537-42.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acromegaly / drug therapy*
  • Adrenocorticotropic Hormone / metabolism
  • Aminoglutethimide / therapeutic use
  • Bromocriptine / therapeutic use
  • Calcitonin / therapeutic use
  • Cushing Syndrome / drug therapy*
  • Diazoxide / therapeutic use
  • Diphosphonates / therapeutic use
  • Estrogens / therapeutic use
  • Fluid Therapy
  • Hemangiopericytoma / complications
  • Humans
  • Hypercalcemia / therapy*
  • Hyperthyroidism / etiology
  • Hyperthyroidism / physiopathology
  • Hyperthyroidism / therapy
  • Hypoglycemia / therapy*
  • Inappropriate ADH Syndrome / therapy
  • Ketoconazole / therapeutic use
  • Mifepristone / therapeutic use
  • Mineralocorticoids / metabolism
  • Mitotane / therapeutic use
  • Octreotide / therapeutic use
  • Osteomalacia / etiology
  • Osteomalacia / therapy*
  • Pamidronate
  • Paraneoplastic Endocrine Syndromes / classification
  • Paraneoplastic Endocrine Syndromes / drug therapy*
  • Phosphorus / therapeutic use
  • Plicamycin / therapeutic use
  • Propylthiouracil / therapeutic use
  • Saline Solution, Hypertonic / therapeutic use
  • Somatostatin / analogs & derivatives
  • Somatostatin / therapeutic use
  • Thyroid Neoplasms / complications

Substances

  • Diphosphonates
  • Estrogens
  • Mineralocorticoids
  • Saline Solution, Hypertonic
  • Aminoglutethimide
  • Phosphorus
  • Mifepristone
  • Bromocriptine
  • Somatostatin
  • Propylthiouracil
  • Mitotane
  • Adrenocorticotropic Hormone
  • Calcitonin
  • Plicamycin
  • Diazoxide
  • Pamidronate
  • Ketoconazole
  • Octreotide